B.C.-based Lifestyle Delivery Systems Inc. has announced its wholly owned subsidiary, Core Isogenics Inc., has begun nursery operations in cannabis plant genetic development at its environmentally controlled facility in Adelanto, Calif.

“The goal is to control all aspects of plant genetics with consistent and repeatable cannabinoid, terpene and flavonoid profile compositions,” notes a press release from Lifestyle Delivery Systems, which licenses its technology to a state-of-the-art production and packaging facility in Southern California.

Claiming the process will foster product consistency unmatched in the industry, “the plants that will be developed by Core Isogenics will have defined yields and precise genetic profiles for Core Isogenics’ cultivation as well as contract growers,” it reports.

“The Core Isogenics nursery will develop its plant genetics technology and produce seeds with identical properties to the formulas required for multiple versions of CannaStrips, thereby reducing the number of extraction steps currently required to extract ingredients from more than one plant to a single plant extraction with the exact ingredients already in its DNA,” the statement explains.

Seeds will then be germinated inside of the “climate-controlled, negatively pressurized and remotely monitored rooms to ensure contaminant-free plant development. The seedlings from the nursery will be transported to Core Isogenics’ automated cultivation environment. which will maximize plant growth and shorten grow cycle,” it adds.

The annual production is estimated to be more than 3 million isogenic seeds. “These isogenic strains will be developed for both indoor and outdoor cultivation, with a focus on future large outdoor farms,” the statement notes.

“The medicinal future of cannabis depends on the ability of cultivators and manufacturers to deliver the same exacting ingredients consistently,” maintains Brad Eckenweiler, CEO of Lifestyle Delivery Systems. “That is only possible if those ingredients can be repeated harvest after harvest, which can be achieved only through the complete control of the cannabis plant genetics,” Eckenweiler emphasizes.

“Currently the cannabis market is a menagerie of cross strains constantly splicing and cloning creating weaker and weaker genetics in search of THC, which has resulted in the need for many cultivators to use herbicides, fungicides and pesticides. We believe our approach can change the direction of cannabis cultivation for the better,” he adds.